Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Acoustic Liquid Handling Mass Spectrometry Hailed as Breakthrough Technology at European Summit

ELRIG honors Labcyte with its Technology Prize

November 21, 2017

SAN JOSE, CA

Labcyte Inc. today announced that its Echo® Acoustic Mass Spectrometry platform was awarded the Technology Prize during the European Laboratory Research & Innovation Group’s (ELRIG) annual Drug Discovery event in Liverpool, UK.


The award was presented by ELRIG Chairman Steve Rees during the two-day international conference, which was attended by more than 1,200 delegates from pharma, biotech, academia and the drug discovery vendor community. ELRIG is a not-for-profit organization serving the life science & drug discovery communities.


“We are thrilled to have received this recognition, especially since it was based on the votes of the meeting attendees,” said Mark Fischer-Colbrie, Chief Executive Officer at Labcyte. “Our goal is to continue our expansion of Acoustic-MS, with new applications, new workflows and enhanced integration into existing drug discovery processes.”


Acoustic liquid dispensing, pioneered by Labcyte, uses the gentle energy of sound waves to move minute quantities of liquid with precision and accuracy. In collaboration with AstraZeneca and Waters, this technology was enhanced to generate a mass spectrometry (MS)-friendly mist of nano-droplets, in a process called Acoustic Mist Ionization (AMI).


Mass spectrometers are currently used to quantify the amount of a target analyte present in screening assays, drug metabolism studies, and safety and efficacy experiments. Acoustic-MS combines the speed and low sample consumption of acoustic liquid handling with the label free nature of mass spectrometry. The system has demonstrated the ability to dramatically reduce both cost and cycle time in early drug discovery.


AstraZeneca has already employed the technology’s significant capabilities, recently completing a full library screen in excess of 2 million compounds in less than six weeks.


The two companies have also teamed up with pharmaceutical company GSK to further advance and test the technology in anticipation of a commercial Acoustic-MS system designed to support a broad range of biochemical and cell-based assays.



About Labcyte Inc.

Labcyte, a global biotechnology tools company headquartered in San Jose, California, is revolutionizing liquid handling. Echo® liquid handling systems uses sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical and biotechnology industries, as well as by hospitals, service laboratories, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics and personalized medicine. Labcyte has 61 U.S. patents and others internationally. For more information, visit www.labcyte.com.


PR Contact:
Nicole Litchfield
Bioscribe, Inc.
415-793-6468
nicole@bioscribe.com





MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP